Chemical Compound Review:
Biapenem (4R,5R,6S)-3-(3,5-diaza-1...
Synonyms:
Omegacin, PubChem5820, Omegacin (TN), SureCN49242, CHEMBL285347, ...
This record was replaced with 71340.
- Catalytic mechanism of class B2 metallo-beta-lactamase. Xu, D., Xie, D., Guo, H. J. Biol. Chem. (2006)
- Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Yang, Y., Testa, R.T., Bhachech, N., Rasmussen, B.A., Bush, K. Antimicrob. Agents Chemother. (1999)
- Novel Pseudomonas aeruginosa gene that suppresses tolerance to carbapenems. Taniguchi, K., Ono, T., Murakami, K., Viducic, D., Kayama, S., Hirota, K., Nemoto, K., Miyake, Y. Antimicrob. Agents Chemother. (2003)
- In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems. Weiss, W.J., Petersen, P.J., Jacobus, N.V., Lin, Y.I., Bitha, P., Testa, R.T. Antimicrob. Agents Chemother. (1999)
- In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Malanoski, G.J., Collins, L., Wennersten, C., Moellering, R.C., Eliopoulos, G.M. Antimicrob. Agents Chemother. (1993)
- A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J.M., Dideberg, O. J. Mol. Biol. (2005)
- Biapenem. Perry, C.M., Ibbotson, T. Drugs (2002)
- Contribution of enzymatic properties, cell permeability, and enzyme expression to microbiological activities of beta-lactams in three Bacteroides fragilis isolates that harbor a metallo-beta-lactamase gene. Rasmussen, B.A., Yang, Y., Jacobus, N., Bush, K. Antimicrob. Agents Chemother. (1994)
- Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis. Nagashima, S., Kozawa, O., Otsuka, T., Kohno, K., Minamoto, M., Yokokawa, M., Kanamaru, M., Uematsu, T. J. Antimicrob. Chemother. (2000)
- Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. Yang, Y., Bhachech, N., Bush, K. J. Antimicrob. Chemother. (1995)
- An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. Horii, T., Kobayashi, M., Sato, K., Ichiyama, S., Ohta, M. J. Antimicrob. Chemother. (1998)
- Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillin. Yeo, S.F., Livermore, D.M. J. Antimicrob. Chemother. (1994)
- Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli. Liebowitz, L.D., Klugman, K.P. S. Afr. Med. J. (1996)
- Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance. Chen, H.Y., Livermore, D.M. J. Antimicrob. Chemother. (1994)
- In vitro and in vivo antibacterial activities of biapenem in the fields of obstetrics and gynecology. Mikamo, H., Sato, Y., Hayasaki, Y., Tamaya, T. Chemotherapy. (2000)
- Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa. Horii, T., Ichiyama, S., Ohta, M., Kobayashi, M. J. Med. Microbiol. (1999)
- In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics. Yamaguchi, T., Hashikita, G., Takahashi, S., Itabashi, A., Yamazaki, T., Maesaki, S. J. Infect. Chemother. (2005)
- Interactions of biapenem with active-site serine and metallo-beta-lactamases. Felici, A., Perilli, M., Segatore, B., Franceschini, N., Setacci, D., Oratore, A., Stefani, S., Galleni, M., Amicosante, G. Antimicrob. Agents Chemother. (1995)
- Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem. Mattoes, H.M., Kuti, J.L., Drusano, G.L., Nicolau, D.P. Clinical therapeutics. (2004)
- Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. Bale, M.J., Jones, R.N., Erwin, M.E. Diagn. Microbiol. Infect. Dis. (1994)
- Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species. Houston, A.K., Jones, R.N. Journal of chemotherapy (Florence, Italy) (1994)
- Activity of biapenem (LJC 10627) against 51 imipenem-resistant bacteria and selection and characterisation of biapenem-resistant mutants. Piddock, L.J., Jin, Y.F. J. Antimicrob. Chemother. (1995)
- Role for rpoS gene of Pseudomonas aeruginosa in antibiotic tolerance. Murakami, K., Ono, T., Viducic, D., Kayama, S., Mori, M., Hirota, K., Nemoto, K., Miyake, Y. FEMS Microbiol. Lett. (2005)
- In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen, H.Y., Livermore, D.M. J. Antimicrob. Chemother. (1994)
- In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide. Hoban, D.J., Jones, R.N., Yamane, N., Frei, R., Trilla, A., Pignatari, A.C. Diagn. Microbiol. Infect. Dis. (1993)
- A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography. Ikeda, K., Ikawa, K., Ikeda, A., Nishikawa, Y., Morikawa, N. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2006)